OAC
VNDA icon

OMERS Administration Corp’s Vanda Pharmaceuticals VNDA Stock Holding History

OMERS Administration Corp’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-139,500
Closed -$788K – 1092
2024
Q2 		$788K Buy
+139,500
New +$720K 0.01% 581

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OMERS Administration Corp's VNDA Position: Q3 2024 in Review

OMERS Administration Corp sold out of Vanda Pharmaceuticals (VNDA) in Q3 2024, closing a stake of 139,500 shares — an estimated $788K sold.

OMERS Administration Corp first reported a position in VNDA in Q2 2024 and held it in 1 quarter. The position peaked at $788K in Q2 2024. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • OMERS Administration Corp reported no remaining Vanda Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 139,500 Vanda Pharmaceuticals shares in Q3 2024, an estimated $788K.
  • OMERS Administration Corp first reported a position in Vanda Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Vanda Pharmaceuticals position peaked at $788K in Q2 2024.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on OMERS Administration Corp's 13F filing for Q3 2024, filed 13 Nov 2024.